EWING, N.J., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that Scott Jackson, chief executive officer, will present an overview of the company at two upcoming healthcare conferences.
Help employers find you! Check out all the jobs and post your resume.
